Professor Höök, who for the past three years has been Professor of Nanoscience for Biophysics at Lund University, is just one in a series of recruitments which Chalmers has made within bioscience. This time the base is in physics and is linked to current research within materials science and nanotechnology. Fredrik Höök is also an entrepreneur and is expected to become a key link between Chalmers and the biotechnology industry in Sweden.
"Chalmers is building on the already successful environment in applied physics. Fredrik Höök's work represents yet another step towards satisfying needs and realising potential within biology and medical applications. The interface between natural science, engineering and medicine can benefit from the unique conditions that exist in Gothenburg. This is expected to lead to new technologies and innovations which could reinforce Swedish healthcare and industry even further. I am convinced that Fredrik Höök will capitalise on these opportunities and develop them optimally together with his fellow researchers," says Chalmers President Karin Markides.
Fredrik Höök's research deals with the development of instrumentation and techniques for improved diagnostics and pharmaceutical development. As a PhD student at Chalmers he was involved in founding the company Q-Sense, which manufactures and sells measuring instruments which are used throughout the world by researchers at universities and hospitals as well as developers in industry. The instruments are used primarily to study how biomolecules interact with different materials, which is a key component in the development of diagnostic sensors. Some years after taking his PhD he was offered a professorship in Lund, where his research group developed a completely new method for analysing membrane proteins.
"We are seeking to use new concepts within nanotechnology coupled with the most recent advances in molecular biology to develop more effective sensors and analysis instruments. The aim is more rapid detection of diseases at an earlier stage. We want to improve existing clinical instruments and develop new ones in order to increase accuracy and reduce cost. Our instruments should be available for use at companies working on pharmaceutical development as well as in hospitals for diagnostic purposes," says Fredrik Höök.
The aim of the research group is to detect disease markers on the individual molecule level. At present, millions of molecules are often needed in a blood sample in order to confirm a disease.
Strong research at Chalmers within areas such as soft materials, supermolecular chemistry and biological imaging will be a significant advantage. Co-operation with the Chalmers Biocentre and Sahlgrenska University Hospital will also make it possible to get even closer to the fundamentals of biology and medicine in a completely new way.
Fredrik Höök feels that world-class research in itself is not enough:
"We have worked our way through to the research front line. The aim now is to get past it and become the leader in the field although we will not succeed in this as an independent research group. We must co-operate with several different disciplines.
As a spin-off from our research we have learnt a great deal about cell membranes and how they melt together. This knowledge is vital within pharmaceutical distribution - a new field of interest for us. It is possible to deal with diseases in a completely new way one you have succeeded in getting past the barrier which the membrane represents and can send the drug directly into the diseased cells. Nature has already solved this in the marvellous process where a sperm and an egg merge. We want to learn how to make use of that principle so that one day we can deliver a drug directly to a predetermined place in the body, such as a cancer cell."
He will also bring with him to Chalmers a research group which will be integrated with the biologically oriented work previously led by Bengt Kasemo at the Department of Chemical Physics.
"There will be a broad range of expertise in the group. We are looking forward to working with different researchers at Chalmers, such as physicists, chemists, bioengineers and electrical engineers. The most gratifying aspect of my work is working with young people with a thirst for knowledge. I also hope to make a strong contribution to undergraduate education at Chalmers."
Contact and more information: Fredrik Höök +46-31 772 61 09; firstname.lastname@example.org
Pressofficer Sofie Hebrand; email@example.com; +46 736-79 35 90
Sofie Hebrand | idw
Flow of cerebrospinal fluid regulates neural stem cell division
22.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Chemists at FAU successfully demonstrate imine hydrogenation with inexpensive main group metal
22.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology